| 1 | Nature Reviews Drug Discovery | 159.2 | 99th | Q1 | SCIE | – | No |
| 2 | Trends in Pharmacological Sciences | 32.4 | 99th | Q1 | SCIE | – | No |
| 3 | Annual Review of Pharmacology and Toxicology | 29.5 | 99th | Q1 | SCIE | – | No |
| 4 | Drug Resistance Updates | 29.1 | 98th | Q1 | SCIE | – | No |
| 5 | Medicinal Research Reviews | 29.1 | 98th | Q1 | SCIE | – | No |
| 6 | Pharmacology and Therapeutics | 28.3 | 98th | Q1 | SCIE | – | No |
| 7 | Pharmacological Reviews | 25.9 | 98th | Q1 | SCIE | – | No |
| 8 | Asian Journal of Pharmaceutical Sciences | 20.5 | 97th | Q1 | SCIE | – | Yes |
| 9 | Pharmacological Research | 19.1 | 97th | Q1 | SCIE | – | Yes |
| 10 | Molecular Therapy | 17.9 | 97th | Q1 | SCIE | – | No |
| 11 | Acta Pharmacologica Sinica | 17.7 | 96th | Q1 | SCIE | – | No |
| 12 | Drug Discovery Today | 16.8 | 96th | Q1 | SCIE | – | No |
| 13 | Journal for ImmunoTherapy of Cancer | 16.6 | 96th | Q1 | SCIE | – | Yes |
| 14 | Biomedicine and Pharmacotherapy | 15.9 | 95th | Q1 | SCIE | – | Yes |
| 15 | Neuropsychopharmacology | 15.7 | 95th | Q1 | SCIE | – | No |
| 16 | Phytotherapy Research | 14.5 | 95th | Q1 | SCIE | – | No |
| 17 | BioDrugs | 13.8 | 94th | Q1 | SCIE | – | No |
| 18 | Cell Chemical Biology | 13.6 | 94th | Q1 | SCIE | – | No |
| 19 | British Journal of Pharmacology | 13.5 | 94th | Q1 | SCIE | – | No |
| 20 | Chinese Herbal Medicines | 13.5 | 94th | Q1 | ESCI | – | Yes |
| 21 | European Neuropsychopharmacology | 13.2 | 93rd | Q1 | SCIE | – | No |
| 22 | Phytomedicine | 13.2 | 93rd | Q1 | SCIE | – | No |
| 23 | Neurotherapeutics | 12.6 | 93rd | Q1 | SCIE | – | Yes |
| 24 | Apoptosis | 12.4 | 92nd | Q1 | SCIE | – | No |
| 25 | Pharmaceutical Biology | 12.4 | 92nd | Q1 | SCIE | – | Yes |
| 26 | Current Opinion in Pharmacology | 12.2 | 92nd | Q1 | SCIE | – | No |
| 27 | Cellular and Molecular Life Sciences | 12 | 91st | Q1 | SCIE | – | Yes |
| 28 | Journal of Enzyme Inhibition and Medicinal Chemistry | 11.9 | 91st | Q1 | SCIE | – | Yes |
| 29 | NEJM Evidence | 11.7 | 91st | Q1 | ESCI | – | No |
| 30 | Medicine in Drug Discovery | 11.5 | 91st | Q1 | – | – | Yes |
| 31 | Current Neuropharmacology | 11.4 | 90th | Q1 | SCIE | – | No |
| 32 | Journal of Ethnopharmacology | 11.2 | 90th | Q1 | SCIE | – | No |
| 33 | European Journal of Medicinal Chemistry | 10.8 | 90th | Q1 | SCIE | – | No |
| 34 | Chinese Medicine (United Kingdom) | 10.4 | 89th | Q1 | SCIE | – | Yes |
| 35 | Journal of Psychopharmacology | 10.3 | 89th | Q1 | SCIE | – | No |
| 36 | Molecular Diagnosis and Therapy | 10 | 89th | Q1 | SCIE | – | No |
| 37 | Clinical Pharmacology and Therapeutics | 9.9 | 88th | Q1 | SCIE | – | No |
| 38 | Expert Review of Vaccines | 9.9 | 88th | Q1 | SCIE | – | Yes |
| 39 | Journal of Food Biochemistry | 9.9 | 88th | Q1 | SCIE | – | No |
| 40 | npj Vaccines | 9.8 | 87th | Q1 | SCIE | – | Yes |
| 41 | Frontiers in Pharmacology | 9.5 | 87th | Q1 | SCIE | – | Yes |
| 42 | Inflammation Research | 9.5 | 87th | Q1 | SCIE | – | No |
| 43 | Biochemical Pharmacology | 9.3 | 87th | Q1 | SCIE | – | No |
| 44 | Intelligent Pharmacy | 9.1 | 86th | Q1 | – | – | Yes |
| 45 | Cardiovascular Drugs and Therapy | 9 | 86th | Q1 | SCIE | – | No |
| 46 | Natural Products and Bioprospecting | 9 | 86th | Q1 | ESCI | – | Yes |
| 47 | Altex | 8.9 | 85th | Q1 | SCIE | – | Yes |
| 48 | Journal of Pharmacy and Pharmaceutical Sciences | 8.8 | 85th | Q1 | SCIE | – | Yes |
| 49 | Pharmaceutical Research | 8.7 | 85th | Q1 | SCIE | – | No |
| 50 | Inflammopharmacology | 8.7 | 84th | Q1 | SCIE | – | No |
| 51 | EXCLI Journal | 8.6 | 84th | Q1 | SCIE | – | Yes |
| 52 | Expert Opinion on Therapeutic Targets | 8.6 | 84th | Q1 | SCIE | – | No |
| 53 | PharmacoEconomics | 8.5 | 83rd | Q1 | SCIE, SSCI | A | No |
| 54 | CNS Neuroscience and Therapeutics | 8.5 | 83rd | Q1 | SCIE | – | Yes |
| 55 | Expert Opinion on Investigational Drugs | 8.5 | 83rd | Q1 | SCIE | – | No |
| 56 | Cancer Biology and Therapy | 8.4 | 83rd | Q1 | SCIE | – | Yes |
| 57 | Drug Safety | 8.4 | 82nd | Q1 | SCIE | – | No |
| 58 | Pharmaceutical Medicine | 8.4 | 82nd | Q1 | ESCI | – | No |
| 59 | Expert Opinion on Therapeutic Patents | 8.3 | 82nd | Q1 | SCIE | – | No |
| 60 | International Journal of Neuropsychopharmacology | 8.3 | 81st | Q1 | SCIE | – | Yes |
| 61 | Saudi Pharmaceutical Journal | 8.2 | 81st | Q1 | SCIE | – | Yes |
| 62 | Neuropharmacology | 8.1 | 81st | Q1 | SCIE | – | No |
| 63 | Environmental Toxicology and Pharmacology | 8.1 | 80th | Q1 | SCIE | – | No |
| 64 | International Immunopharmacology | 8.1 | 80th | Q1 | SCIE | – | No |
| 65 | Antimicrobial Agents and Chemotherapy | 8 | 80th | Q1 | SCIE | – | Yes |
| 66 | Current Molecular Pharmacology | 7.8 | 80th | Q1 | SCIE | – | No |
| 67 | Antiviral Research | 7.8 | 79th | Q1 | SCIE | – | No |
| 68 | Psychopharmacology | 7.8 | 79th | Q1 | SCIE | – | No |
| 69 | Vaccines | 7.7 | 79th | Q1 | SCIE | – | Yes |
| 70 | Cannabis and Cannabinoid Research | 7.6 | 78th | Q1 | SCIE | – | No |
| 71 | Clinical Pharmacokinetics | 7.6 | 78th | Q1 | SCIE | – | No |
| 72 | European Journal of Pharmacology | 7.6 | 78th | Q1 | SCIE | – | No |
| 73 | Mini-Reviews in Medicinal Chemistry | 7.5 | 77th | Q1 | SCIE | – | No |
| 74 | Human Vaccines and Immunotherapeutics | 7.4 | 77th | Q1 | SCIE | – | Yes |
| 75 | Open Medicinal Chemistry Journal | 7.3 | 77th | Q1 | – | – | No |
| 76 | British Journal of Clinical Pharmacology | 7.3 | 76th | Q1 | SCIE | – | No |
| 77 | CNS and Neurological Disorders - Drug Targets | 7.3 | 76th | Q1 | SCIE | – | No |
| 78 | Pharmacological Reports | 7.2 | 76th | Q1 | SCIE | – | No |
| 79 | Skin Pharmacology and Physiology | 7 | 76th | Q1 | SCIE | – | No |
| 80 | Bioconjugate Chemistry | 7 | 75th | Q1 | SCIE | – | No |
| 81 | Drug Design, Development and Therapy | 6.9 | 75th | Q1 | SCIE | – | Yes |
| 82 | Drug Metabolism and Disposition | 6.8 | 75th | Q1 | SCIE | – | No |
| 83 | Anti-Cancer Agents in Medicinal Chemistry | 6.7 | 74th | Q2 | SCIE | – | No |
| 84 | Journal of Pharmacy and Pharmacology | 6.7 | 74th | Q2 | SCIE | – | No |
| 85 | Profiles of Drug Substances, Excipients and Related Methodology | 6.7 | 74th | Q2 | – | – | No |
| 86 | Drug and Chemical Toxicology | 6.6 | 73rd | Q2 | SCIE | – | No |
| 87 | Journal of Antimicrobial Chemotherapy | 6.6 | 73rd | Q2 | SCIE | – | No |
| 88 | Expert Opinion on Biological Therapy | 6.5 | 73rd | Q2 | SCIE | – | No |
| 89 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 6.5 | 73rd | Q2 | SCIE | – | No |
| 90 | Current Medicinal Chemistry | 6.5 | 72nd | Q2 | SCIE | – | No |
| 91 | Drug and Alcohol Dependence | 6.5 | 72nd | Q2 | SCIE, SSCI | – | No |
| 92 | Vascular Pharmacology | 6.5 | 72nd | Q2 | SCIE | – | No |
| 93 | Biomolecules and Therapeutics | 6.4 | 71st | Q2 | SCIE | – | No |
| 94 | Frontiers in Drug Delivery | 6.4 | 71st | Q2 | ESCI | – | Yes |
| 95 | Journal of Neuroimmune Pharmacology | 6.4 | 71st | Q2 | SCIE | – | No |
| 96 | Journal of Natural Products | 6.3 | 70th | Q2 | SCIE | – | No |
| 97 | Progress in Medicinal Chemistry | 6.3 | 70th | Q2 | – | – | No |
| 98 | Toxicology and Applied Pharmacology | 6.2 | 70th | Q2 | SCIE | – | No |
| 99 | Cardiovascular Therapeutics | 6.1 | 69th | Q2 | SCIE | – | Yes |
| 100 | Chemical Biology and Drug Design | 6.1 | 69th | Q2 | SCIE | – | No |
| 101 | Pharmacology | 6.1 | 69th | Q2 | SCIE | – | No |
| 102 | Therapeutic Advances in Neurological Disorders | 6.1 | 69th | Q2 | SCIE | – | Yes |
| 103 | Critical Reviews in Therapeutic Drug Carrier Systems | 6 | 68th | Q2 | SCIE | – | No |
| 104 | Current Drug Targets | 6 | 68th | Q2 | SCIE | – | No |
| 105 | Pharmaceutical Science Advances | 5.9 | 68th | Q2 | – | – | Yes |
| 106 | Addiction Biology | 5.9 | 67th | Q2 | SCIE | – | Yes |
| 107 | Chirality | 5.9 | 67th | Q2 | SCIE | – | No |
| 108 | Expert Opinion on Emerging Drugs | 5.9 | 67th | Q2 | SCIE | – | No |
| 109 | Basic and Clinical Pharmacology and Toxicology | 5.9 | 66th | Q2 | SCIE | – | No |
| 110 | Cancer Biotherapy and Radiopharmaceuticals | 5.9 | 66th | Q2 | SCIE | – | No |
| 111 | Current Pharmaceutical Design | 5.8 | 66th | Q2 | SCIE | – | No |
| 112 | Investigational New Drugs | 5.8 | 66th | Q2 | SCIE | – | No |
| 113 | ChemMedChem | 5.7 | 65th | Q2 | SCIE | – | No |
| 114 | Clinical Therapeutics | 5.7 | 65th | Q2 | SCIE | – | No |
| 115 | Pharmacogenomics Journal | 5.7 | 65th | Q2 | SCIE | – | No |
| 116 | Journal of Pharmacological Sciences | 5.7 | 64th | Q2 | SCIE | – | Yes |
| 117 | RSC Medicinal Chemistry | 5.7 | 64th | Q2 | SCIE | – | No |
| 118 | Expert Opinion on Drug Metabolism and Toxicology | 5.6 | 64th | Q2 | SCIE | – | No |
| 119 | Clinical and Experimental Pharmacology and Physiology | 5.6 | 63rd | Q2 | SCIE | – | No |
| 120 | European Journal of Clinical Pharmacology | 5.6 | 63rd | Q2 | SCIE | – | No |
| 121 | Fundamental and Clinical Pharmacology | 5.6 | 63rd | Q2 | SCIE | – | No |
| 122 | Infection and Drug Resistance | 5.6 | 62nd | Q2 | SCIE | – | Yes |
| 123 | Journal of Cardiovascular Pharmacology and Therapeutics | 5.6 | 62nd | Q2 | SCIE | – | Yes |
| 124 | Journal of Cannabis Research | 5.5 | 62nd | Q2 | ESCI | – | Yes |
| 125 | Journal of Food and Drug Analysis | 5.5 | 62nd | Q2 | SCIE | – | No |
| 126 | Journal of Immunotherapy | 5.4 | 61st | Q2 | SCIE | – | No |
| 127 | Diabetes, Metabolic Syndrome and Obesity | 5.3 | 61st | Q2 | SCIE | – | Yes |
| 128 | Immunopharmacology and Immunotoxicology | 5.3 | 61st | Q2 | SCIE | – | No |
| 129 | Drug, Healthcare and Patient Safety | 5.3 | 60th | Q2 | ESCI | – | Yes |
| 130 | Journal of Pharmacology and Experimental Therapeutics | 5.2 | 60th | Q2 | SCIE | – | No |
| 131 | Molecular Pharmacology | 5.2 | 60th | Q2 | SCIE | – | No |
| 132 | ACS Pharmacology and Translational Science | 5.2 | 59th | Q2 | ESCI | – | No |
| 133 | Drug Metabolism and Pharmacokinetics | 5.2 | 59th | Q2 | SCIE | – | No |
| 134 | Journal of Toxicology | 5.2 | 59th | Q2 | ESCI | – | Yes |
| 135 | International Journal of Immunopathology and Pharmacology | 5.1 | 58th | Q2 | SCIE | – | Yes |
| 136 | Journal of Pharmacokinetics and Pharmacodynamics | 5.1 | 58th | Q2 | SCIE | – | No |
| 137 | Journal of Xenobiotics | 5.1 | 58th | Q2 | ESCI | – | Yes |
| 138 | PharmaNutrition | 5.1 | 58th | Q2 | ESCI | – | No |
| 139 | Journal of Experimental Pharmacology | 5.1 | 57th | Q2 | – | – | Yes |
| 140 | Drugs in Context | 5 | 57th | Q2 | ESCI | – | Yes |
| 141 | Medical Cannabis and Cannabinoids | 5 | 57th | Q2 | – | – | Yes |
| 142 | Frontiers in Antibiotics | 5 | 56th | Q2 | ESCI | – | Yes |
| 143 | Frontiers in Drug Discovery | 5 | 56th | Q2 | ESCI | – | Yes |
| 144 | Microbial Drug Resistance | 5 | 56th | Q2 | SCIE | – | No |
| 145 | International Journal of Clinical Pharmacy | 5 | 55th | Q2 | SCIE | – | No |
| 146 | Journal of Clinical Pharmacy and Therapeutics | 5 | 55th | Q2 | SCIE | – | No |
| 147 | Advanced Therapeutics | 4.9 | 55th | Q2 | SCIE | – | No |
| 148 | Naunyn-Schmiedeberg's Archives of Pharmacology | 4.9 | 55th | Q2 | SCIE | – | No |
| 149 | Antiviral Therapy | 4.9 | 54th | Q2 | SCIE | – | Yes |
| 150 | Biomarker Insights | 4.9 | 54th | Q2 | ESCI | – | Yes |
| 151 | Drug and Alcohol Dependence Reports | 4.9 | 54th | Q2 | ESCI | – | Yes |
| 152 | European Journal of Drug Metabolism and Pharmacokinetics | 4.9 | 53rd | Q2 | SCIE | – | No |
| 153 | Expert Opinion on Pharmacotherapy | 4.8 | 53rd | Q2 | SCIE | – | No |
| 154 | Steroids | 4.8 | 53rd | Q2 | SCIE | – | No |
| 155 | DARU, Journal of Pharmaceutical Sciences | 4.8 | 52nd | Q2 | SCIE | – | No |
| 156 | Pharmacogenomics and Personalized Medicine | 4.8 | 52nd | Q2 | SCIE | – | Yes |
| 157 | Journal of Basic and Clinical Physiology and Pharmacology | 4.7 | 52nd | Q2 | – | – | No |
| 158 | Journal of Clinical Pharmacology | 4.7 | 51st | Q2 | SCIE | – | No |
| 159 | Journal of Ocular Pharmacology and Therapeutics | 4.7 | 51st | Q2 | SCIE | – | No |
| 160 | Planta Medica | 4.7 | 51st | Q2 | SCIE | – | No |
| 161 | Cancer Chemotherapy and Pharmacology | 4.6 | 51st | Q2 | SCIE | – | No |
| 162 | Anti-Cancer Drugs | 4.6 | 50th | Q2 | SCIE | – | No |
| 163 | Journal of Antibiotics | 4.6 | 50th | Q2 | SCIE | – | No |
| 164 | Pharmacology Biochemistry and Behavior | 4.6 | 50th | Q2 | SCIE | – | No |
| 165 | Current Pharmacology Reports | 4.6 | 49th | Q3 | ESCI | – | No |
| 166 | Journal of Cardiovascular Pharmacology | 4.6 | 49th | Q3 | SCIE | – | No |
| 167 | Revista Espanola de Quimioterapia | 4.5 | 49th | Q3 | SCIE | – | Yes |
| 168 | Prostaglandins and Other Lipid Mediators | 4.5 | 48th | Q3 | SCIE | – | No |
| 169 | Advances in Pharmacology | 4.4 | 48th | Q3 | – | – | No |
| 170 | Future Medicinal Chemistry | 4.4 | 48th | Q3 | SCIE | – | No |
| 171 | EJNMMI Radiopharmacy and Chemistry | 4.3 | 48th | Q3 | ESCI | – | Yes |
| 172 | Clinical Trials | 4.3 | 47th | Q3 | SCIE | – | No |
| 173 | PharmacoEconomics - Open | 4.3 | 47th | Q3 | ESCI | – | Yes |
| 174 | Current Cancer Drug Targets | 4.2 | 47th | Q3 | SCIE | – | No |
| 175 | Biopharmaceutics and Drug Disposition | 4.2 | 46th | Q3 | SCIE | – | No |
| 176 | Journal of AOAC International | 4.2 | 46th | Q3 | SCIE | – | No |
| 177 | Therapeutic Drug Monitoring | 4.2 | 46th | Q3 | SCIE | – | No |
| 178 | BMC Pharmacology and Toxicology | 4.1 | 45th | Q3 | SCIE | – | Yes |
| 179 | Experimental and Clinical Psychopharmacology | 4.1 | 45th | Q3 | SCIE, SSCI | – | No |
| 180 | Topics in Antiviral Medicine | 4.1 | 45th | Q3 | – | – | No |
| 181 | Journal of Chemotherapy | 4.1 | 44th | Q3 | SCIE | – | No |
| 182 | Drugs in R and D | 4 | 44th | Q3 | SCIE | – | Yes |
| 183 | Journal of the American Pharmacists Association | 4 | 44th | Q3 | SCIE | – | No |
| 184 | Current Drug Metabolism | 3.9 | 44th | Q3 | SCIE | – | No |
| 185 | Fitoterapia | 3.9 | 43rd | Q3 | SCIE | – | No |
| 186 | Journal of Pharmacological and Toxicological Methods | 3.8 | 43rd | Q3 | SCIE | – | No |
| 187 | RSC Pharmaceutics | 3.8 | 43rd | Q3 | ESCI | – | Yes |
| 188 | Autophagy Reports | 3.8 | 42nd | Q3 | – | – | Yes |
| 189 | Journal of Peptide Science | 3.8 | 42nd | Q3 | SCIE | – | No |
| 190 | Current Therapeutic Research - Clinical and Experimental | 3.7 | 42nd | Q3 | ESCI | – | Yes |
| 191 | Current Cardiovascular Risk Reports | 3.7 | 41st | Q3 | ESCI | – | No |
| 192 | Current Vascular Pharmacology | 3.6 | 41st | Q3 | SCIE | – | No |
| 193 | Trends in Phytochemical Research | 3.6 | 41st | Q3 | – | – | No |
| 194 | Bulletin of Mathematical Biology | 3.6 | 40th | Q3 | SCIE | – | No |
| 195 | Chemotherapy | 3.6 | 40th | Q3 | SCIE | – | No |
| 196 | Drug Development and Industrial Pharmacy | 3.6 | 40th | Q3 | SCIE | – | No |
| 197 | Korean Journal of Physiology and Pharmacology | 3.5 | 40th | Q3 | SCIE | – | No |
| 198 | Journal of Physiology and Pharmacology | 3.5 | 39th | Q3 | SCIE | – | No |
| 199 | American Journal of Therapeutics | 3.4 | 39th | Q3 | SCIE | – | No |
| 200 | Biologicals | 3.4 | 39th | Q3 | SCIE | – | No |
| 201 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | 3.4 | 38th | Q3 | – | – | No |
| 202 | Canadian Journal of Physiology and Pharmacology | 3.3 | 38th | Q3 | SCIE | – | No |
| 203 | In Vivo | 3.3 | 38th | Q3 | SCIE | – | No |
| 204 | Biomedical Chromatography | 3.3 | 37th | Q3 | SCIE | – | No |
| 205 | International Journal of Medicinal Mushrooms | 3.3 | 37th | Q3 | SCIE | – | No |
| 206 | Current Radiopharmaceuticals | 3.2 | 37th | Q3 | SCIE | – | No |
| 207 | Journal of Veterinary Pharmacology and Therapeutics | 3.2 | 37th | Q3 | SCIE | – | No |
| 208 | Acta Pharmaceutica | 3.2 | 36th | Q3 | SCIE | – | Yes |
| 209 | Records of Natural Products | 3.2 | 36th | Q3 | SCIE | – | No |
| 210 | Journal of Pharmacopuncture | 3.1 | 36th | Q3 | ESCI | – | Yes |
| 211 | Biological and Pharmaceutical Bulletin | 3.1 | 35th | Q3 | SCIE | – | Yes |
| 212 | Pharmacogenomics | 3 | 35th | Q3 | SCIE | – | No |
| 213 | Current Medicinal Chemistry: Cardiovascular and Hematological Agents | 2.9 | 35th | Q3 | – | – | No |
| 214 | Infectious Disorders - Drug Targets | 2.9 | 35th | Q3 | – | – | No |
| 215 | Neuropsychopharmacology Reports | 2.9 | 34th | Q3 | ESCI | – | Yes |
| 216 | Journal of Asian Natural Products Research | 2.8 | 34th | Q3 | SCIE | – | No |
| 217 | American Journal of Health-System Pharmacy | 2.8 | 33rd | Q3 | SCIE | – | No |
| 218 | Clinical and Experimental Vaccine Research | 2.8 | 33rd | Q3 | ESCI | – | Yes |
| 219 | Emerging Trends in Drugs, Addictions, and Health | 2.8 | 33rd | Q3 | – | – | Yes |
| 220 | Journal of Herbs, Spices and Medicinal Plants | 2.8 | 33rd | Q3 | ESCI | – | No |
| 221 | Behavioural Pharmacology | 2.7 | 32nd | Q3 | SCIE | – | No |
| 222 | Personalized Medicine | 2.7 | 32nd | Q3 | SCIE | – | No |
| 223 | Reading Teacher | 2.7 | 32nd | Q3 | SSCI | – | No |
| 224 | Journal of Biopharmaceutical Statistics | 2.7 | 31st | Q3 | SCIE | C | No |
| 225 | Clinical Neuropharmacology | 2.7 | 31st | Q3 | SCIE | – | No |
| 226 | Natural Product Communications | 2.7 | 31st | Q3 | SCIE | – | Yes |
| 227 | Arabian Journal of Medicinal and Aromatic Plants | 2.6 | 30th | Q3 | – | – | No |
| 228 | Contemporary Clinical Trials Communications | 2.6 | 30th | Q3 | ESCI | – | Yes |
| 229 | Pharmaceutical Statistics | 2.6 | 30th | Q3 | SCIE | – | No |
| 230 | Reviews on Recent Clinical Trials | 2.6 | 30th | Q3 | ESCI | – | No |
| 231 | Journal of Pharmacy and Pharmacognosy Research | 2.5 | 29th | Q3 | ESCI | – | Yes |
| 232 | Pharmacognosy Journal | 2.5 | 29th | Q3 | – | – | No |
| 233 | Xenobiotica | 2.5 | 29th | Q3 | SCIE | – | No |
| 234 | Annales Pharmaceutiques Francaises | 2.4 | 28th | Q3 | ESCI | – | No |
| 235 | Expert Review of Precision Medicine and Drug Development | 2.3 | 28th | Q3 | ESCI | – | No |
| 236 | Journal of Biologically Active Products from Nature | 2.3 | 28th | Q3 | ESCI | – | No |
| 237 | Pharmaceutical Fronts | 2.3 | 27th | Q3 | ESCI | – | Yes |
| 238 | Indian Journal of Pharmacology | 2.1 | 27th | Q3 | SCIE | – | No |
| 239 | Research Results in Biomedicine | 2.1 | 27th | Q3 | – | – | No |
| 240 | Current Drug Safety | 2 | 26th | Q3 | ESCI | – | No |
| 241 | Mathematical Medicine and Biology | 2 | 26th | Q3 | SCIE | – | No |
| 242 | Tropical Journal of Natural Product Research | 1.9 | 26th | Q3 | – | – | No |
| 243 | Farmacia Hospitalaria | 1.8 | 26th | Q3 | ESCI | – | Yes |
| 244 | Cardiovascular and Hematological Disorders - Drug Targets | 1.8 | 25th | Q3 | – | – | No |
| 245 | Hospital Pharmacy | 1.8 | 25th | Q3 | ESCI | – | No |
| 246 | Journal of Medicinal Plants | 1.8 | 25th | Q3 | – | – | Yes |
| 247 | Journal of Pharmacology and Pharmacotherapeutics | 1.8 | 24th | Q4 | ESCI | – | No |
| 248 | International Journal of Drug Discovery and Pharmacology | 1.7 | 24th | Q4 | – | – | Yes |
| 249 | Muscles | 1.7 | 24th | Q4 | ESCI | – | Yes |
| 250 | Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas | 1.6 | 23rd | Q4 | SCIE | – | No |
| 251 | Pharmaceutical Chemistry Journal | 1.6 | 23rd | Q4 | SCIE | – | No |
| 252 | Biomedical and Pharmacology Journal | 1.5 | 23rd | Q4 | – | – | No |
| 253 | International Journal of Clinical Pharmacology and Therapeutics | 1.5 | 23rd | Q4 | SCIE | – | No |
| 254 | Anti-Infective Agents | 1.4 | 22nd | Q4 | – | – | No |
| 255 | Current Issues in Pharmacy and Medical Sciences | 1.4 | 22nd | Q4 | ESCI | – | Yes |
| 256 | Toxicology Communications | 1.4 | 22nd | Q4 | ESCI | – | Yes |
| 257 | Bangladesh Journal of Pharmacology | 1.3 | 21st | Q4 | SCIE | – | Yes |
| 258 | Pharmacological Research - Natural Products | 1.3 | 21st | Q4 | – | – | No |
| 259 | Side Effects of Drugs Annual | 1.3 | 21st | Q4 | – | – | No |
| 260 | Borneo Journal of Pharmacy | 1.2 | 20th | Q4 | – | – | Yes |
| 261 | Journal of Respiratory Biology and Translational Medicine | 1.2 | 20th | Q4 | – | – | No |
| 262 | Regulatory Mechanisms in Biosystems | 1.2 | 20th | Q4 | ESCI | – | Yes |
| 263 | Farmakoekonomika | 1.2 | 19th | Q4 | – | – | Yes |
| 264 | Herba Polonica | 1.2 | 19th | Q4 | – | – | Yes |
| 265 | Research Results in Pharmacology | 1.2 | 19th | Q4 | – | – | Yes |
| 266 | Thai Journal of Pharmaceutical Sciences | 1.2 | 19th | Q4 | – | – | No |
| 267 | European Journal of Oncology Pharmacy | 1.1 | 18th | Q4 | – | – | No |
| 268 | Farmatsiya i Farmakologiya | 1.1 | 18th | Q4 | ESCI | – | Yes |
| 269 | Physiology and Pharmacology (Iran) | 1.1 | 18th | Q4 | ESCI | – | Yes |
| 270 | Ankara Universitesi Eczacilik Fakultesi Dergisi | 1 | 17th | Q4 | – | – | No |
| 271 | Chinese Pharmaceutical Journal | 1 | 17th | Q4 | – | – | No |
| 272 | Medical Letter on Drugs and Therapeutics | 1 | 17th | Q4 | SCIE | – | No |
| 273 | Chinese Pharmacological Bulletin | 0.9 | 16th | Q4 | – | – | No |
| 274 | Current Topics in Pharmacology | 0.9 | 16th | Q4 | – | – | No |
| 275 | Food and Drug Law Journal | 0.9 | 16th | Q4 | SCIE, SSCI | – | No |
| 276 | Reviews on Clinical Pharmacology and Drug Therapy | 0.9 | 16th | Q4 | – | – | No |
| 277 | Acta Poloniae Pharmaceutica - Drug Research | 0.8 | 15th | Q4 | SCIE | – | Yes |
| 278 | Bulletin of Pharmaceutical Sciences. Assiut | 0.8 | 15th | Q4 | – | – | Yes |
| 279 | Chinese Journal of Hospital Pharmacy | 0.8 | 15th | Q4 | – | – | No |
| 280 | Analytical Science and Technology | 0.7 | 14th | Q4 | ESCI | – | No |
| 281 | Issues in Toxicology | 0.7 | 14th | Q4 | – | – | No |
| 282 | Ukrains'kij Zurnal Vijskovoi Medicini | 0.7 | 14th | Q4 | – | – | Yes |
| 283 | Journal of Applied Pharmaceutical Research | 0.7 | 13th | Q4 | – | – | Yes |
| 284 | Chinese Journal of Pharmacovigilance | 0.6 | 13th | Q4 | – | – | No |
| 285 | Indian Journal of Physiology and Pharmacology | 0.6 | 13th | Q4 | – | – | No |
| 286 | Adverse Drug Reaction Bulletin | 0.6 | 12th | Q4 | – | – | No |
| 287 | China Pharmacy | 0.6 | 12th | Q4 | – | – | Yes |
| 288 | Farmaceuticos Comunitarios | 0.6 | 12th | Q4 | ESCI | – | Yes |
| 289 | Yakugaku Zasshi | 0.6 | 12th | Q4 | SCIE | – | No |
| 290 | Indian Drugs | 0.6 | 11th | Q4 | – | – | No |
| 291 | Journal of Natural Remedies | 0.5 | 11th | Q4 | – | – | No |
| 292 | Phytotherapie | 0.5 | 11th | Q4 | – | – | No |
| 293 | Current Pharmacogenomics and Personalized Medicine | 0.5 | 10th | Q4 | – | – | No |
| 294 | Journal of China Pharmaceutical University | 0.5 | 10th | Q4 | – | – | No |
| 295 | Prescrire International | 0.5 | 10th | Q4 | – | – | No |
| 296 | Folia Pharmacologica Japonica | 0.4 | 9th | Q4 | – | – | No |
| 297 | Journal of Phytomedicine and Therapeutics | 0.4 | 9th | Q4 | – | – | No |
| 298 | Pharmacotherapy in Psychiatry and Neurology | 0.4 | 9th | Q4 | – | – | No |
| 299 | Chinese Journal of Clinical Pharmacology and Therapeutics | 0.4 | 8th | Q4 | – | – | No |
| 300 | Eksperimental'naya i Klinicheskaya Farmakologiya | 0.4 | 8th | Q4 | – | – | No |